Lemon Bottle (10ml)

Lemon Bottle (10 ml): A Korean-Developed Lipolytic (Fat-Dissolving) Injectable Solution Marketed for Non-Surgical Localized Fat Reduction, Formulated with a Proprietary Bioactive Complex Including Riboflavin (Vitamin B2), Bromelain (Pineapple-Derived Proteolytic Enzyme), and Lecithin (Phosphatidylcholine-Containing Phospholipid Emulsifier), Along with Supplementary Botanical Extracts Including Ananas Sativus (Pineapple) Fruit Extract, Centella Asiatica (Gotu Kola) Extract, Salvia Miltiorrhiza Root Extract, and Chamomilla Recutita (Matricaria) Extract — Administered by Intradermal or Subcutaneous Injection into Targeted Subcutaneous Fat Deposits (Such as Double Chin, Jowls, Abdomen, Flanks, Thighs, and Arms) by Licensed Aesthetic Professionals, with a Proposed Mechanism of Adipocytolysis (Targeted Fat Cell Destruction) Involving Lecithin-Mediated Fat Cell Membrane Disruption, Bromelain-Assisted Tissue Breakdown and Post-Injection Anti-Inflammatory Effects, and Riboflavin-Supported Metabolic Activation — Classified as a Cosmetic Product Rather Than a Regulated Medical Device or Pharmaceutical in Most Jurisdictions, Meaning It Has Not Undergone the Rigorous Clinical Testing Required of Medical Products, and Peer-Reviewed Clinical Evidence Specifically Supporting Its Combined Fat-Dissolving Effect in Human Subjects Remains Limited as of 2026 — With Common Side Effects Including Injection Site Redness, Swelling, Pain, Bruising, and Tenderness, and Potential Risks Including Fat Necrosis, Skin Unevenness or Dimpling, Infection, Allergic Reactions, and Vascular Complications if Improperly Administered — Intended for Use by Trained Aesthetic Practitioners Only, Not for Self-Administration

Lemon Bottle is a Korean-developed lipolytic (fat-dissolving) injectable solution that has gained popularity in aesthetic medicine for non-surgical localized fat reduction. Marketed under the brand name Lemonbottle (with the core product presented as Lemonbottle Ampoule Solution 10ml for face and body), this product is designed for administration by licensed aesthetic professionals via intradermal or subcutaneous injection into targeted subcutaneous fat deposits — including the double chin (submental fat), jawline and jowls, abdomen, flanks ("love handles"), thighs, arms, and other areas of localized fat accumulation that are resistant to diet and exercise. The product is supplied as a single-presentation injectable ampoule containing 10 ml of the proprietary bioactive complex solution, with a characteristic yellow color attributed to its riboflavin (vitamin B2) content. The manufacturer markets Lemon Bottle as a non-surgical alternative to liposuction for patients who are close to their ideal body weight but struggle with stubborn fat pockets, emphasizing that — unlike surgical liposuction — there is no need for general anesthesia, no large incisions, no significant downtime, and no scars, while acknowledging that results are typically less dramatic and more gradual than surgical fat removal. It is important to note from the outset that Lemon Bottle is classified as a cosmetic product rather than a regulated medical device or pharmaceutical in most jurisdictions, which means it has not undergone the rigorous clinical testing, safety evaluation, and regulatory approval process required of prescription medical products. Furthermore, as noted by independent reviewers and aesthetic medicine analysts, no mechanistic study of Lemon Bottle (the specific combination of ingredients) exists in peer-reviewed literature as of 2026, and peer-reviewed clinical evidence specifically supporting the combined fat-dissolving effect of its ingredient profile in human subjects remains limited. The closest validated mechanism for the lipolytic-injection class generally is deoxycholate-mediated adipocyte lysis (Rotunda et al., 2004, PMID 15209790) — but Lemon Bottle's label does not include deoxycholate, distinguishing it from deoxycholic acid-based products such as Kybella/Belkyra (the only FDA-approved injectable for submental fat reduction) and Aqualyx (a polymer-based slow-release deoxycholate formulation widely used in Europe and Asia). This distinction is critical for understanding both the proposed mechanism and the evidence base for Lemon Bottle, which relies primarily on phosphatidylcholine (from lecithin), bromelain, and riboflavin rather than on the well-characterized detergent mechanism of bile acids^{[1][2][3][4][5][6][7][8][9][10][11][12]}.

Ingredient Profile and Proposed Mechanism of Action

The marketed active ingredients of Lemon Bottle, as listed by the manufacturer and confirmed by multiple supplier and aesthetic clinic sources, include three primary bioactive components plus a range of supplementary botanical extracts and excipients. It is important to note that the full formulation is not publicly disclosed in complete detail by the manufacturer, and different sources may list slightly different ingredient profiles — a common characteristic of cosmetic-grade injectable products. The primary marketed ingredients and their proposed roles are as follows^{[1][2][3][4][5][6][7][8][9][10][11][12]}:

Riboflavin (Vitamin B2): Riboflavin is a water-soluble B-vitamin that serves as an essential cofactor in numerous metabolic processes, including the metabolism of fats, carbohydrates, and proteins. In the context of Lemon Bottle, riboflavin is marketed as the "catalyst" or "powerhouse" of the formula, claimed to activate and accelerate fat cell metabolism — setting the stage for fat breakdown by supporting the mitochondrial energy pathways involved in lipid oxidation. Riboflavin is also responsible for the characteristic yellow color of the solution. From a pharmacological perspective, riboflavin's role in fat metabolism is well-established at the systemic level (it is a precursor to flavin adenine dinucleotide [FAD] and flavin mononucleotide [FMN], coenzymes critical for β-oxidation of fatty acids in mitochondria), but its role in localized fat breakdown when injected subcutaneously at the concentrations used in Lemon Bottle is theoretical and not clinically established in injectable form. The manufacturer's proposed mechanism suggests that riboflavin "activates fat metabolism" as the first step in a three-step process, but there is no peer-reviewed evidence demonstrating that subcutaneous riboflavin injection at these concentrations produces localized fat loss through metabolic activation^{[1][2][3][4][5][6][7][8][9][10][11][12]}.

Bromelain: Bromelain is a proteolytic (protein-digesting) enzyme complex derived from the stems and fruit of pineapple (Ananas comosus). It has a long history of use as a dietary supplement and natural anti-inflammatory agent, with documented biological activity including protein digestion, anti-inflammatory effects (through inhibition of pro-inflammatory mediators such as bradykinin and prostaglandins), anti-edema effects (reducing swelling by improving circulation and breaking down fibrin), and potential fibrinolytic activity. In the context of Lemon Bottle, bromelain is marketed as playing a dual role: first, it is claimed to help break down fat tissue (through its proteolytic activity on extracellular matrix proteins that support adipose tissue structure), and second, it is claimed to reduce post-injection inflammation and swelling — potentially improving patient comfort and recovery time. Bromelain's anti-inflammatory and anti-edema effects are supported by some clinical evidence when taken orally, particularly for post-surgical swelling and sinusitis, but its role in fat cell breakdown at injectable concentrations is claimed by the manufacturer but not rigorously established in peer-reviewed literature. The enzyme's proteolytic activity could theoretically contribute to tissue remodeling and breakdown of the extracellular matrix surrounding fat cells, but whether this translates to clinically meaningful fat reduction when combined with the other Lemon Bottle ingredients remains an open question^{[1][2][3][4][5][6][7][8][9][10][11][12]}.

Lecithin (Phosphatidylcholine): Lecithin is a generic term for a mixture of phospholipids, with phosphatidylcholine (PC) being the primary bioactive component. Phosphatidylcholine is a major structural component of all cell membranes and is also involved in lipid transport and metabolism. In the context of injectable lipolysis, phosphatidylcholine has been used for many years in "injection lipolysis" formulations (often combined with deoxycholate), with a proposed mechanism involving emulsification and disruption of fat cell membranes. The mechanism of action of phosphatidylcholine in subcutaneous fat lysis has been the subject of significant debate in the medical literature. Early theories, based on phosphatidylcholine's known effects on systemic triglyceride levels and its ability to emulsify fats for transport, hypothesized that PC was the active lipolytic ingredient — stimulating lipases to split triglycerides into fatty acids and glycerol, with fatty acids metabolized by the liver and glycerol being water-soluble and readily excreted. However, subsequent research by Rotunda et al. in 2004 (PMID 15209790) revealed that sodium deoxycholate (SDC) — a bile salt commonly included in PC-based injection lipolysis formulations — was likely the actual active ingredient, acting as a biological detergent that disrupts cell membranes and causes dose-dependent cellular lysis in cultured cells. This finding was significant because it suggested that the fat-dissolving effects attributed to phosphatidylcholine in earlier studies may have actually been due to the deoxycholate component. Lemon Bottle's formulation, which contains lecithin/phosphatidylcholine but does not list deoxycholate on its label, therefore relies on phosphatidylcholine's proposed membrane-disrupting and emulsifying effects without the well-characterized detergent action of bile acids. Whether phosphatidylcholine alone — at the concentrations used in Lemon Bottle — can produce clinically meaningful adipocyte lysis remains a subject of debate and limited clinical evidence. Some practitioners and manufacturers argue that the combination of phosphatidylcholine with bromelain and riboflavin produces a synergistic effect that compensates for the absence of deoxycholate, but this synergy has not been validated in controlled clinical trials^{[1][2][3][4][5][6][7][8][9][10][11][12]}.

Supplementary botanical extracts and excipients: In addition to the three primary active ingredients, Lemon Bottle's formulation includes a range of supplementary components, as listed in the manufacturer's ingredient disclosure: Water (Aqua) as the base solvent; Ananas Sativus (Pineapple) Fruit Extract (additional bromelain source and antioxidant); Pentylene Glycol (humectant and penetration enhancer); Sodium Chloride (isotonicity agent); Centella Asiatica (Gotu Kola) Extract (claimed to boost collagen production, improve skin elasticity, and reduce cellulite appearance); Salvia Miltiorrhiza (Danshen) Root Extract (traditional Chinese medicine herb with potential anti-inflammatory and circulatory effects); Chamomilla Recutita (Matricaria) Extract (calming, anti-inflammatory, and soothing agent); and other unspecified excipients and preservatives. These botanical extracts are primarily included for their claimed skin-soothing, anti-inflammatory, and tissue-supporting properties, rather than as primary fat-dissolving agents. Centella Asiatica, in particular, is included in many aesthetic products for its purported effects on collagen synthesis and skin elasticity, which the manufacturer suggests may help improve skin tightness and reduce cellulite appearance in treated areas. The inclusion of multiple anti-inflammatory botanicals (chamomile, gotu kola, danshen, pineapple) is consistent with the manufacturer's emphasis on reducing post-treatment swelling and discomfort — a key selling point compared to more aggressive deoxycholate-based formulations that can cause significant inflammation^{[1][2][3][4][5][6][7][8][9][10][11][12]}.

Evidence Assessment and Important Caveats: It is essential to approach Lemon Bottle with a critical and evidence-based perspective. As noted by independent aesthetic medicine analysts and reviewers: (1) No mechanistic study of Lemon Bottle (the specific combination) exists in peer-reviewed literature — the closest validated mechanism for the lipolytic-injection class is deoxycholate-mediated adipocyte lysis (Rotunda 2004, PMID 15209790), but Lemon Bottle's label does not include deoxycholate; (2) Peer-reviewed clinical evidence specifically supporting the combined fat-dissolving effect of Lemon Bottle's ingredient profile in human subjects remains limited as of 2026 — while individual ingredients (phosphatidylcholine, bromelain, riboflavin) have documented biological activity, their synergistic effect when injected subcutaneously at the concentrations used in this product has not been rigorously validated in large, randomized, controlled trials; (3) Lemon Bottle is classified as a cosmetic product, not a medical device or pharmaceutical, in most jurisdictions — this means it has not undergone the rigorous testing required of medical products, and its safety and efficacy profiles are not as thoroughly characterized as FDA-approved or CE-marked medical devices; (4) The full formulation is not publicly disclosed in complete detail by the manufacturer, and different sources may list slightly different ingredient profiles — a common characteristic of cosmetic-grade injectable products that makes precise pharmacokinetic and pharmacodynamic assessment difficult; (5) Results are typically less dramatic and more gradual than surgical liposuction, and multiple treatment sessions (typically 2-4 sessions spaced 2-3 weeks apart) are usually required to achieve visible results; (6) The product is intended for use by trained aesthetic practitioners only — improper injection technique, incorrect depth, or injection into vascular structures can lead to serious complications including tissue necrosis, vascular occlusion, infection, and scarring; (7) Patients should be counseled that injectable lipolysis products are not weight-loss solutions — they are designed for localized fat reduction in patients who are at or near their ideal body weight, and they do not replace diet, exercise, or bariatric interventions for clinically significant obesity; (8) Long-term safety data (5+ years) are limited for this specific product, and the potential for delayed adverse effects or recurrence of treated fat deposits has not been fully characterized in long-term follow-up studies. Patients considering Lemon Bottle or any injectable lipolysis product should consult with a qualified, board-certified aesthetic physician or dermatologist, review before-and-after photographs from the practitioner's own patients, discuss realistic expectations and potential risks, and ensure that the product being used is authentic and obtained from authorized distributors (counterfeit aesthetic products are a significant concern in the global market)^{[1][2][3][4][5][6][7][8][9][10][11][12]}.

Comparison with Other Injectable Lipolysis Products and Surgical Alternatives

To understand Lemon Bottle's position in the aesthetic fat reduction market, it is helpful to compare it with other injectable lipolysis products and with surgical alternatives. The three main categories of non-surgical injectable fat reduction are: (1) deoxycholic acid-based products (Kybella/Belkyra, Aqualyx, Desobody, Desoface), which rely on the well-characterized detergent mechanism of bile acid-mediated adipocyte membrane disruption; (2) phosphatidylcholine-based products (Lemon Bottle, various PC/DC formulations), which rely on the more debated emulsification and membrane-disrupting effects of phospholipids; and (3) other mechanisms (e.g., deoxycholate + phosphatidylcholine combinations, caffeine-based formulations, herbal lipolytic cocktails). Kybella (synthetic deoxycholic acid) is the only injectable product FDA-approved for submental fat reduction, with robust clinical trial data demonstrating significant fat reduction compared to placebo, but it is associated with significant post-treatment swelling, pain, and a risk of marginal mandibular nerve injury. Aqualyx (a polymer-based slow-release deoxycholate formulation developed by Professor Motolese in Italy) is widely used in Europe, Asia, and Latin America for body and face fat reduction, with a large clinical experience base (over 14 years and thousands of patients in published series) but limited randomized controlled trial data compared to Kybella. Lemon Bottle, as a phosphatidylcholine-based product without deoxycholate, is positioned by its manufacturer as a gentler alternative with potentially less post-treatment inflammation and swelling (due to the inclusion of multiple anti-inflammatory botanicals and the absence of the aggressive detergent action of bile acids), but this positioning comes at the cost of a less well-characterized mechanism and a thinner clinical evidence base. Surgical alternatives — including traditional liposuction, laser-assisted liposuction (SmartLipo), ultrasound-assisted liposuction (VASER), and energy-assisted liposuction — remain the gold standard for larger-volume fat removal and more dramatic results, with the trade-off of requiring anesthesia, incisions, downtime, and surgical risks. For patients seeking minimal-downtime, non-surgical, localized fat reduction in small to moderate treatment areas, injectable lipolysis products like Lemon Bottle can be a viable option when administered by qualified practitioners, but patients should have realistic expectations and understand that results are typically gradual, may require multiple sessions, and are less dramatic than surgical fat removal^{[1][2][3][4][5][6][7][8][9][10][11][12]}.

Safety, Side Effects, and Administration Considerations

Lemon Bottle, like all injectable aesthetic products, carries potential risks and side effects that should be thoroughly discussed with patients before treatment. The safety profile of Lemon Bottle is generally considered favorable when administered by trained practitioners using proper technique, but adverse events can and do occur. Common, expected side effects — typically mild to moderate and self-limiting, resolving within 3-14 days — include: injection site redness (erythema), swelling (edema), pain or tenderness during and after injection, bruising (ecchymosis), itching (pruritus), warmth or heat sensation at the treatment site, and temporary firmness or nodularity under the skin as the inflammatory clearance process progresses. The manufacturer's inclusion of multiple anti-inflammatory botanicals (chamomile, gotu kola, danshen, pineapple/bromelain) is specifically intended to minimize these post-treatment inflammatory effects, and many practitioners report that Lemon Bottle is associated with less swelling and downtime compared to deoxycholate-based products — though this comparative claim has not been validated in head-to-head clinical trials. Less common but more concerning potential adverse effects include: fat necrosis (death of fat tissue, which can present as firm, painful nodules and may require surgical excision if persistent); skin unevenness, dimpling, or contour irregularities (due to uneven fat dissolution or improper injection technique); infection (bacterial infection at injection sites, which can be minimized by proper aseptic technique); allergic or hypersensitivity reactions (to any of the product ingredients, particularly bromelain [pineapple allergy] or botanical extracts); vascular complications (if the product is inadvertently injected into a blood vessel, which can cause vascular occlusion, tissue ischemia, and necrosis — this is a rare but serious complication that requires immediate medical attention); nerve injury (if injection is too deep or near nerve pathways, particularly in the submental/jawline area where the marginal mandibular nerve is vulnerable); pigmentary changes (post-inflammatory hyperpigmentation or hypopigmentation, more common in darker skin types); and scarring (rare, but possible with deep injections, infection, or tissue necrosis). Contraindications to Lemon Bottle treatment include: pregnancy and breastfeeding (insufficient safety data); known allergy or hypersensitivity to any product ingredient (especially pineapple/bromelain allergy); active skin infection or inflammation at the treatment site; autoimmune disease or immunocompromised state (relative contraindication); bleeding disorders or use of anticoagulant medications (relative contraindication, increased bruising risk); history of keloid or hypertrophic scar formation (relative contraindication); severe obesity (injectable lipolysis is not appropriate for large-volume fat removal); and unrealistic expectations or body dysmorphic disorder. Treatment should only be administered by licensed, trained aesthetic professionals — physicians, nurse practitioners, physician assistants, or registered nurses with specialized training in injectable aesthetics — using proper aseptic technique, appropriate injection depth (intradermal or superficial subcutaneous, depending on the treatment area and practitioner protocol), and accurate anatomical knowledge to avoid vascular and nerve structures. Patients should be advised to avoid blood-thinning medications and supplements (aspirin, NSAIDs, fish oil, vitamin E) for 1-2 weeks before treatment if medically appropriate, to minimize bruising; to avoid strenuous exercise, alcohol, and heat exposure (saunas, hot tubs) for 24-48 hours after treatment; to apply cold compresses to reduce swelling; and to massage the treated area gently as directed by the practitioner (post-treatment massage is often recommended to enhance fat elimination and reduce nodularity). Multiple treatment sessions — typically 2-4 sessions spaced 2-3 weeks apart — are usually required to achieve optimal visible results, and maintenance treatments may be needed periodically as fat cells can potentially regenerate or adjacent fat deposits can become more prominent with weight changes. As with all aesthetic treatments, patients should ensure that the product being used is authentic, obtained from authorized distributors, and within its expiration date — counterfeit aesthetic injectable products are a significant global concern and can contain unknown, potentially dangerous ingredients^{[1][2][3][4][5][6][7][8][9][10][11][12]}.

References

1. StackTrax / Lemon Bottle: The Complete Guide. stacktrax.com. 2026. (No mechanistic study of Lemon Bottle [specific combination] exists in peer-reviewed literature; closest validated mechanism for lipolytic-injection class = deoxycholate-mediated adipocyte lysis [Rotunda 2004, PMID 15209790] — but Lemon Bottle label does not include deoxycholate; marketed active ingredients: riboflavin [vitamin B2], bromelain, lecithin [phosphatidylcholine]; full formulation not publicly disclosed; recurring concern: full formulation not publicly...)
2. Injectco / Lemon Bottle Honest Review (2026): Side Effects, Fat Dissolving Results, Before & After, Does It Really Work? injectco.com. 2026. (Manufacturer lists active ingredients: riboflavin [Vitamin B2] — water-soluble vitamin involved in energy metabolism, role in fat breakdown theoretical and not clinically established in injectable form; bromelain — proteolytic enzyme from pineapple, some evidence for reducing inflammation/edema post-procedure, role in fat cell breakdown at injectable concentrations claimed but not rigorously established; lecithin...; peer-reviewed clinical evidence specifically supporting combined fat-dissolving effect in human subjects remains limited as of 2026)
3. Standard Peptides / Lemon Bottle. standardpeptides.com. 2026. (Marketed active ingredients commonly listed as: riboflavin [vitamin B2] — water-soluble vitamin + metabolic cofactor that gives solution its yellow color; bromelain — proteolytic [protein-digesting], anti-inflammatory enzyme derived from pineapple; lecithin [phosphatidylcholine] — emulsifier that can disrupt fat-cell membranes; some formulations also list caffeine; recurring concern: full formulation not publicly disclosed)
4. Skin On You / Lemon Bottle vs Aqualyx: Clinical Comparison of Fat Dissolving Injectables for Aesthetic Practitioners. skinonyou.com. 2025. (Lemon Bottle composition: Phosphatidylcholine [PPC] — emulsifies fat cell membranes; Sodium Deoxycholate [DC] — bile salt that disrupts adipocyte membranes [NOTE: some sources list DC, but manufacturer label and other sources do not list deoxycholate — discrepancy noted]; L-Carnitine — supports fatty acid metabolism; Vitamin B12 — cofactor in metabolic processes; proposed mechanism: adipocyte lysis followed by inflammatory clearance + gradual volume reduction; Aqualyx = polymer-based slow-release deoxycholate formulation)
5. Amorefill / Fat Dissolving Injections: A Complete Practitioner Guide. amorefill.com. 2026. (Deoxycholic acid [DCA] — direct cytolysis: naturally occurring bile acid that disrupts phospholipid membranes via detergent mechanism; when injected into subcutaneous fat, rapidly disrupts adipocyte membranes → releasing intracellular lipids + triggering acute inflammatory response; inflammation recruits macrophages that engulf cellular debris → cleared via lymphatic system + metabolized by liver; this is mechanism of Aqualyx + Kybella/Belkyra; phosphatidylcholine mechanism debated — early theory: PC stimulates lipases → splits triglycerides into fatty acids + glycerol; subsequent research [Rotunda 2004] found deoxycholate likely active ingredient)
6. PMC / Injection Lipolysis: A Systematic Review of Literature and Our Experience with a Combination of Phosphatidylcholine and Deoxycholate over 14 Years in 1269 Patients. PMC6371720. 2019. (Mechanism of PC in lysis of subcutaneous fat still matter of research; postulated that PC stimulates lipases + splits triglycerides into fatty acids + glycerol; fatty acids metabolized by liver, glycerol water-soluble; number of studies mention PC acting as chemical substance making lipids water soluble → stimulates lipases causing triglycerides to break into fatty acids + glycerol; Sodium DC is...; 14-year experience, 1269 patients, Indian + Southeast Asian population)
7. PMC / Injection Adipolysis: Mechanisms, Agents, and Future Directions. PMC5300726. 2017. (Theory based on PC's effect on systemic triglyceride levels + ability to emulsify fats for transport → hypothesis that PC was active ingredient; subsequent research by Rotunda et al 2004 revealed that SDC [sodium deoxycholate] was likely active ingredient, acting as biologic detergent + disrupting cell viability; laboratory experiments revealed dose-dependent cellular lysis in cultured cells exposed to SDC; PC alone may have limited adipolytic effect without deoxycholate)
8. Rejuva London / The Lemon Bottle Fat Dissolving Treatment. rejvalondon.co.uk. 2025. (Non-surgical fat reduction with Lemon Bottle works through adipocytolysis — targeted destruction of fat cells; active ingredient claimed = deoxycholic acid [NOTE: this source claims deoxycholic acid, but manufacturer label + other sources list riboflavin/bromelain/lecithin — significant discrepancy in marketing claims across sources]; naturally occurring bile acid that bodies produce to help break down dietary fat; when injected directly into subcutaneous fat, disrupts fat cell membrane through detergent-like action → cell ruptures + releases contents; similar to how washing-up liquid breaks down grease on dishes; body clears fatty acids through normal lymphatic drainage + metabolic processing over 4-6 weeks)
9. Lemonbottle.website / How Lemon Bottle Fat Dissolving works? lemonbottle.website. 2026. (Manufacturer's claimed 3-step mechanism: Step 1 — Vitamin B2 [riboflavin] serves as catalyst for fat metabolism activation, setting stage for fat breakdown; Step 2 — Lecithin destroys + transports unnecessary fat cells, effectively broken down + mobilized for removal; Step 3 — Bromelain plays dual role in breaking...; manufacturer marketing claims, not peer-reviewed validated mechanism)
10. Medical Spa Rx / LEMONBOTTLE. medicalsparx.com. 2026. (LEMONBOTTLE AMPOULE SOLUTION 10ml = original + authentic core product, single-presentation injectable ampoule for non-surgical fat reduction; each 10ml ampoule contains proprietary bioactive complex of riboflavin, bromelain, lecithin; administered by licensed aesthetic professional via intradermal or subcutaneous injection, depth +...)
11. Axiom Aesthetics / Fat Dissolving Injections: Aqualyx, Lemon Bottle, and More. axiomaesthetics.co.uk. 2026. (Not a regulated medical product: Lemon Bottle classified as cosmetic product, not medical device or pharmaceutical → has not undergone rigorous testing required of medical products; Questionable mechanism: manufacturer claims product dissolves fat through blend of riboflavin [vitamin B2], bromelain [pineapple enzyme], lecithin; while these are recognised substances, evidence that they can effectively dissolve fat when injected at concentrations used is limited...)
12. My Skin Korea / Lemon bottle ingredient profile. myskinkorea.com. 2026. (Ingredient table: Riboflavin [Vitamin B2] — activates + accelerates fat cell metabolism, "powerhouse" of formula; Lecithin — destroys fat cell membranes + transports dissolved fat for natural excretion; Bromelain [Ananas Sativus / Pineapple Extract] — breaks down fat tissue + reduces post-injection inflammation; Centella Asiatica [Gotu Kola] — boosts collagen, improves skin elasticity, reduces cellulite; full ingredient list per manufacturer: Water, Ananas Sativus [Pineapple] Fruit Extract, Pentylene Glycol, Bromelain, Sodium Chloride, Lecithin, Centella Asiatica Extract, Salvia Miltiorrhiza Root Extract, Chamomilla Recutita [Matricaria] Extract, Sc...)
13. Rotunda AM, Kolodney MS. Mesosomal lipolysis: controlled laboratory investigations of deoxycholate and phosphatidylcholine. Dermatol Surg. 2004;30(8):1130-1135. PMID: 15209790. (Found that sodium deoxycholate [SDC] was likely active ingredient in PC/DC injection lipolysis, acting as biologic detergent + disrupting cell viability; dose-dependent cellular lysis in cultured cells exposed to SDC; phosphatidylcholine alone had limited cytotoxic effect; landmark study that changed understanding of injection lipolysis mechanism)
14. Fraya Med Supply / Lemon Bottle 5x10ml. frayamedsupply.com. 2026. (Composition listed by this supplier: Phosphatidylcholine [PPC] — natural compound that emulsifies + breaks down fat cells for efficient elimination; Deoxycholate [DC] — bile acid that enhances fat cell destruction + boosts contouring results [NOTE: this supplier lists DC, but manufacturer label + other sources do not — significant discrepancy]; L-Carnitine — stimulates metabolism to accelerate breakdown + removal of fat; Contains 5 x 10ml vials; Space sessions 2-3 weeks apart; Post-treatment massage enhances fat elimination)